KRAS and cancer: In K-RAS-activated oncogenic NIH3T3 mouse fibroblasts, the crucial contribution of glutamine-derived DNA precursors to cancer cell progression was demonstrated by showing that glutamine deprivation prevented cells from entering the S-phase and significantly reduced cell proliferation, and that these effects were canceled by restoring the four deoxyribonucleotides [48].